Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 11, 2025

Primary Completion Date

September 11, 2027

Study Completion Date

September 11, 2027

Conditions

Heart Transplant Infection Prevention

Interventions

DRUG

Commercial measles, mumps, and rubella (MMR) vaccine

Participants will receive the commercial MMR vaccine if they are deemed eligible for the study.

Trial Locations (1)

RECRUITING

Children's Mercy Hospital, Kansas City

All Listed Sponsors

lead

Children's Mercy Hospital Kansas City

OTHER